GSE132681
Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells [ChIP-seq]
Human acute myeloid leukemia (AML) KG1a cells  or mouse BM cells (mouse bone morrow cells were employed for each ChIP assay. The ChIP procedure was performed according to a previously described protocol (Lee et al., 2006; Ying et al., 2017), using anti-ATF4 antibody (Abcam) Overall design: ChIP-sequencing (ChIP-seq) of ATF4  in human AML KG1a cells and mouse BM cells. Input samples included.